New patent for Currax drug SILENOR

   March 3, 2022    Comments Off on New patent for Currax drug SILENOR    Posted in: Patent Added

Annual Drug Patent Expirations for SILENOR Silenor is a drug marketed by Currax and is included in one NDA. It is available from three suppliers. There are fourteen patents protecting…

The post New patent for Currax drug SILENOR appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog